284 related articles for article (PubMed ID: 28065853)
1. Sitagliptin inhibit human lymphocytes proliferation and Th1/Th17 differentiation in vitro.
Pinheiro MM; Stoppa CL; Valduga CJ; Okuyama CE; Gorjão R; Pereira RM; Diniz SN
Eur J Pharm Sci; 2017 Mar; 100():17-24. PubMed ID: 28065853
[TBL] [Abstract][Full Text] [Related]
2. Sitagliptin, a DPP-4 inhibitor, alters the subsets of circulating CD4+ T cells in patients with type 2 diabetes.
Aso Y; Fukushima M; Sagara M; Jojima T; Iijima T; Suzuki K; Momobayashi A; Kasai K; Inukai T
Diabetes Res Clin Pract; 2015 Dec; 110(3):250-6. PubMed ID: 26508675
[TBL] [Abstract][Full Text] [Related]
3. DPP-4 (CD26) inhibitor sitagliptin exerts anti-inflammatory effects on rat insulinoma (RINm) cells via suppressing NF-κB activation.
Hu X; Liu S; Liu X; Zhang J; Liang Y; Li Y
Endocrine; 2017 Mar; 55(3):754-763. PubMed ID: 27612849
[TBL] [Abstract][Full Text] [Related]
4. DPP4 inhibition by sitagliptin attenuates LPS-induced lung injury in mice.
Kawasaki T; Chen W; Htwe YM; Tatsumi K; Dudek SM
Am J Physiol Lung Cell Mol Physiol; 2018 Nov; 315(5):L834-L845. PubMed ID: 30188745
[TBL] [Abstract][Full Text] [Related]
5. Sitagliptin Induces Tolerogenic Human Dendritic Cells.
Drakul M; Tomić S; Bekić M; Mihajlović D; Vasiljević M; Rakočević S; Đokić J; Popović N; Bokonjić D; Čolić M
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069152
[TBL] [Abstract][Full Text] [Related]
6. Dipeptidyl Peptidase 4 Inhibitors Reduce Hepatocellular Carcinoma by Activating Lymphocyte Chemotaxis in Mice.
Nishina S; Yamauchi A; Kawaguchi T; Kaku K; Goto M; Sasaki K; Hara Y; Tomiyama Y; Kuribayashi F; Torimura T; Hino K
Cell Mol Gastroenterol Hepatol; 2019; 7(1):115-134. PubMed ID: 30510994
[TBL] [Abstract][Full Text] [Related]
7. Type 1 Diabetes Prevention in NOD Mice by Targeting DPPIV/CD26 Is Associated with Changes in CD8⁺T Effector Memory Subset.
Alonso N; Julián MT; Carrascal J; Colobran R; Pujol-Autonell I; Rodriguez-Fernández S; Teniente A; Fernández MA; Miñarro A; Ruiz de Villa MC; Vives-Pi M; Puig-Domingo M
PLoS One; 2015; 10(11):e0142186. PubMed ID: 26555789
[TBL] [Abstract][Full Text] [Related]
8. The increased T helper cells proliferation and inflammatory responses in patients with type 2 diabetes mellitus is suppressed by sitagliptin and vitamin D3 in vitro.
Mahabadi-Ashtiyani E; Sheikh V; Borzouei S; Salehi I; Alahgholi-Hajibehzad M
Inflamm Res; 2019 Oct; 68(10):857-866. PubMed ID: 31236602
[TBL] [Abstract][Full Text] [Related]
9. The mechanism of sitagliptin inhibition of colorectal cancer cell lines' metastatic functionalities.
Varela-Calviño R; Rodríguez-Quiroga M; Dias Carvalho P; Martins F; Serra-Roma A; Vázquez-Iglesias L; Páez de la Cadena M; Velho S; Cordero OJ
IUBMB Life; 2021 May; 73(5):761-773. PubMed ID: 33615655
[TBL] [Abstract][Full Text] [Related]
10. The new insights from DPP-4 inhibitors: their potential immune modulatory function in autoimmune diabetes.
Zhao Y; Yang L; Wang X; Zhou Z
Diabetes Metab Res Rev; 2014 Nov; 30(8):646-53. PubMed ID: 24446278
[TBL] [Abstract][Full Text] [Related]
11. Involvement of CD26 in Differentiation and Functions of Th1 and Th17 Subpopulations of T Lymphocytes.
Zhao X; Wang W; Zhang K; Yang J; Fuchs H; Fan H
J Immunol Res; 2021; 2021():6671410. PubMed ID: 33542930
[TBL] [Abstract][Full Text] [Related]
12. DPP-4 Inhibition Leads to Decreased Pancreatic Inflammatory Profile and Increased Frequency of Regulatory T Cells in Experimental Type 1 Diabetes.
Davanso MR; Caliari-Oliveira C; Couri CEB; Covas DT; de Oliveira Leal AM; Voltarelli JC; Malmegrim KCR; Yaochite JNU
Inflammation; 2019 Apr; 42(2):449-462. PubMed ID: 30707388
[TBL] [Abstract][Full Text] [Related]
13. The effect of dipeptidyl peptidase-IV inhibition on circulating T cell subpopulations in patients with type 2 diabetes mellitus.
Sromova L; Busek P; Posova H; Potockova J; Skrha P; Andel M; Sedo A
Diabetes Res Clin Pract; 2016 Aug; 118():183-92. PubMed ID: 27388675
[TBL] [Abstract][Full Text] [Related]
14. Is there an impact of treatment with DPP-4 inhibitors on lymphocyte subpopulations in type 2 diabetic patients?
Strojek K; Górska J; Rokicka D; Szymborska-Kajanek A; Wróbel M; Sędek Ł; Szczepański T
Endokrynol Pol; 2014; 65(2):78-82. PubMed ID: 24802729
[TBL] [Abstract][Full Text] [Related]
15. Effects of the Antidiabetic Drugs Evogliptin and Sitagliptin on the Immune Function of CD26/DPP4 in Th1 Cells.
Yoon H; Sung JH; Song MJ
Biomol Ther (Seoul); 2021 Mar; 29(2):154-165. PubMed ID: 33148870
[TBL] [Abstract][Full Text] [Related]
16. Effects of short-term sitagliptin treatment on immune parameters in healthy individuals, a randomized placebo-controlled study.
Price JD; Linder G; Li WP; Zimmermann B; Rother KI; Malek R; Alattar M; Tarbell KV
Clin Exp Immunol; 2013 Oct; 174(1):120-8. PubMed ID: 23711188
[TBL] [Abstract][Full Text] [Related]
17. Dipeptidyl peptidase-4 inhibitor sitagliptin improves pancreatic β-cell function in hypertensive diabetic patients treated with angiotensin receptor blockers.
Fukui K; Kawahito H; Wakana N; Kikai M; Terada K; Yamamoto K; Irie D; Kato T; Miyagawa S; Yamada H
J Renin Angiotensin Aldosterone Syst; 2015 Dec; 16(4):1001-9. PubMed ID: 26195265
[TBL] [Abstract][Full Text] [Related]
18. Soluble CD26 / dipeptidyl peptidase IV enhances human lymphocyte proliferation in vitro independent of dipeptidyl peptidase enzyme activity and adenosine deaminase binding.
Yu DM; Slaitini L; Gysbers V; Riekhoff AG; Kähne T; Knott HM; De Meester I; Abbott CA; McCaughan GW; Gorrell MD
Scand J Immunol; 2011 Feb; 73(2):102-11. PubMed ID: 21198750
[TBL] [Abstract][Full Text] [Related]
19. Dipeptidyl peptidase-IV inhibition prevents blood-retinal barrier breakdown, inflammation and neuronal cell death in the retina of type 1 diabetic rats.
Gonçalves A; Marques C; Leal E; Ribeiro CF; Reis F; Ambrósio AF; Fernandes R
Biochim Biophys Acta; 2014 Sep; 1842(9):1454-63. PubMed ID: 24769045
[TBL] [Abstract][Full Text] [Related]
20. CD26 costimulatory blockade improves lung allograft rejection and is associated with enhanced interleukin-10 expression.
Yamada Y; Jang JH; De Meester I; Baerts L; Vliegen G; Inci I; Yoshino I; Weder W; Jungraithmayr W
J Heart Lung Transplant; 2016 Apr; 35(4):508-17. PubMed ID: 26755203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
